$5.50
-0.110 (-1.96%)
At Close: Jul 13, 2026
Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders
04:07pm, Thursday, 02'nd Jul 2026
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
NDRA Stock Alert: Halper Sadeh LLC is Investigating Whether ENDRA Life Sciences Inc. is Obtaining a Fair Price for its Shareholders
02:00pm, Thursday, 25'th Jun 2026
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ENDRA Life Sciences Inc. (NASDAQ: NDRA) with Noble Africa LLC. Upon closing of the
NDRA Stock Alert: Halper Sadeh LLC is Investigating Whether ENDRA Life Sciences Inc. is Obtaining a Fair Price for its Shareholders
01:44pm, Thursday, 25'th Jun 2026
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ENDRA Life Sciences Inc. (NASDAQ: NDRA) with Noble Africa LLC. Upon closing of the proposed tra
ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," âASPIâ or the "Company"), an advanced materials company focused on developing technologies and processes
DALLAS & ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," “ASPI” or the "Company"), an advanced materials company focused on developing technol
Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen's Virginia Gas Project Listing expected to provide investors with direct exposure to one of th
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
08:00am, Monday, 18'th May 2026
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and mo
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
08:00am, Thursday, 14'th May 2026
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for the early detection an
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
04:05pm, Tuesday, 31'st Mar 2026
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and mo
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
08:00am, Wednesday, 25'th Mar 2026
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and mo
ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday
01:58am, Monday, 23'rd Mar 2026
ENDRA Life Sciences (NASDAQ: NDRA - Get Free Report) is expected to be issuing its Q4 2025 results before the market opens on Monday, March 30th. Analysts expect the company to announce earnings of ($
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
11:15am, Tuesday, 03'rd Mar 2026
ENDRA posts strong TAEUS Liver study data, showing high measurement reliability for MASLD monitoring and boosting its regulatory and commercial outlook.
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for the early detection an
ENDRA's TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
08:00am, Thursday, 04'th Dec 2025
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #MASH--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermo-acoustic biomarker imaging for early detection and mo
Critical Contrast: Pulse Biosciences (NASDAQ:PLSE) vs. ENDRA Life Sciences (NASDAQ:NDRA)
03:47am, Saturday, 22'nd Nov 2025
ENDRA Life Sciences (NASDAQ: NDRA - Get Free Report) and Pulse Biosciences (NASDAQ: PLSE - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast t
Sign In
Buy NDRA